Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|February 6, 2016
[The significance of biobanks for clinical development]Marlene Thomas, Astrid Kiermaier, Michael CannarileAustralasian Journal on Ageing|November 17, 2017
Use of and satisfaction with Community Aged Care Packages in the eastern suburbs of SydneyMarlene Thomas, Brian Woodhouse, Jenny Rees-Mackenzie, et al.Journal of Clinical Bioinformatics|May 7, 2013
An optimized workflow for improved gene expression profiling for formalin-fixed, paraffin-embedded tumor samplesMarlene Thomas, Manuela Poignée-Heger, Martin Weisser, et al.Lung Cancer (Amsterdam, Netherlands)|April 9, 2022
Genomic testing among patients with newly diagnosed advanced non-small cell lung cancer in the United States: A contemporary clinical practice patterns studyLuis Paz-Ares, Adam Gondos, Diego Saldana, et al.Cancer Chemotherapy and Pharmacology|May 13, 2017
Accelerating drug development by efficiently using emerging PK/PD data from an adaptable entry-into-human trial: example of lumretuzumabGeorgina Meneses-Lorente, Christine McIntyre, Joy C Hsu, et al.Cancer Chemotherapy and Pharmacology|February 23, 2015
Preclinical pharmacokinetics, pharmacodynamics, and efficacy of RG7116: a novel humanized, glycoengineered anti-HER3 antibodyGeorgina Meneses-Lorente, Thomas Friess, Irene Kolm, et al.Molecular & Cellular Proteomics : MCP|June 25, 2015
Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)Sabine Bader, Magdalena Zajac, Thomas Friess, et al.The American Journal of Pathology|June 4, 2013
Detection of truncated HER2 forms in formalin-fixed, paraffin-embedded breast cancer tissue captures heterogeneity and is not affected by HER2-targeted therapyJuliane M Krüger, Marlene Thomas, René Korn, et al.Pancreas|January 31, 2016
Profiling of cMET and HER Family Receptor Expression in Pancreatic Ductal Adenocarcinomas and Corresponding Lymph Node Metastasis to Assess Relevant Pathways for Targeted Therapies: Looking at the Soil Before Planting the SeedAlexander Muckenhuber, Galina Babitzki, Marlene Thomas, et al.Proteomics|December 17, 2013
Applications of mass spectrometry for quantitative protein analysis in formalin-fixed paraffin-embedded tissuesCarine Steiner, Axel Ducret, Jean-Christophe Tille, et al.Pageof 3